Research location
Cangzhou
Hebei, China
Advertisement
Research activity in Cangzhou
Hebei, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 54 trials and 61 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Cangzhou
54 linked trials · page 1 of 2AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsNCT07797335 · 2026-08-24 · 1 site observation
RECRUITING
Smartwatch-based Intervention for Cardiovascular Health (SWITCH)NCT07372729 · 2026-03-24 · 1 site observation
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesNCT07351058 · 2026-03-23 · 1 site observation
RECRUITING
A Clinical Trial on the Efficacy and Safety of TQB6411 for InjectionNCT07367529 · 2026-02-26 · 2 site observations
RECRUITING
A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung CancerNCT07253142 · 2026-02-05 · 1 site observation
RECRUITING
Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal MetastasesNCT07304739 · 2025-12-22 · 1 site observation
RECRUITING
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerNCT07043725 · 2025-09-15 · 1 site observation
RECRUITING
Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid TumorsNCT07058948 · 2025-07-01 · 1 site observation
RECRUITING
TQC2731 Clinical Trial for the Treatment of Severe Asthma With InjectionNCT06829784 · 2025-03-21 · 1 site observation
RECRUITING
JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C MutationNCT06416410 · 2024-08-07 · 1 site observation
RECRUITING
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative DementiaNCT06534658 · 2020-07-30 · 1 site observation
RECRUITING
LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and DyslipidemiaNCT07350486 · 2026-05-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid TumorsNCT07160335 · 2025-09-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07147946 · 2025-09-01 · 1 site observation
NOT_YET_RECRUITING
Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.NCT06922903 · 2025-04-01 · 1 site observation
NOT_YET_RECRUITING
A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical TreatmentNCT06922929 · 2025-04-01 · 1 site observation
NOT_YET_RECRUITING
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese SubjectsNCT06738979 · 2025-03-20 · 2 site observations
COMPLETED
A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT06789289 · 2025-03-17 · 1 site observation
ACTIVE_NOT_RECRUITING
A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT06707883 · 2024-12-31 · 1 site observation
ACTIVE_NOT_RECRUITING
A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT06527144 · 2024-09-14 · 1 site observation
COMPLETED
HTA of NIVATS Based on RWENCT06574295 · 2024-08-20 · 1 site observation
COMPLETED
Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and DurvalumabNCT06211036 · 2024-06-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 DiabetesNCT06350890 · 2023-11-05 · 1 site observation
COMPLETED
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)NCT05607550 · 2023-06-01 · 1 site observation
ACTIVE_NOT_RECRUITING
FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast CancerNCT05755048 · 2023-03-28 · 1 site observation
UNKNOWN
A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes MellitusNCT05816057 · 2022-07-25 · 3 site observations
COMPLETED
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast CancerNCT05365178 · 2022-07-01 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast CancerNCT05433480 · 2022-05-25 · 1 site observation
UNKNOWN
A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung CancerNCT05353257 · 2022-05-17 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast CancerNCT05346224 · 2022-04-25 · 1 site observation
ACTIVE_NOT_RECRUITING
China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)NCT05221580 · 2022-03-18 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe AsthmaNCT05155020 · 2022-02-11 · 1 site observation
TERMINATED
Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes MellitusNCT05102149 · 2021-09-30 · 1 site observation
UNKNOWN
Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential HypertensionNCT05359068 · 2021-06-10 · 1 site observation
COMPLETED
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)NCT04795531 · 2021-03-24 · 1 site observation
COMPLETED
Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.NCT04251156 · 2020-12-08 · 2 site observations
COMPLETED
Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With DiabetesNCT04588259 · 2020-10-09 · 1 site observation
COMPLETED
Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based ChemotherapyNCT04447118 · 2020-09-11 · 1 site observation
COMPLETED
A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in ChinaNCT04830826 · 2020-07-09 · 1 site observation
COMPLETED
A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in ChinaNCT04227431 · 2020-01-17 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)NCT04093752 · 2019-12-09 · 1 site observation
COMPLETED
A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 DiabetesNCT04109547 · 2019-10-01 · 1 site observation
COMPLETED
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLCNCT04033354 · 2019-08-14 · 1 site observation
UNKNOWN
A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 DiabetesNCT04017832 · 2019-07-29 · 1 site observation
COMPLETED
A Heart Disease Study of Semaglutide in Patients With Type 2 DiabetesNCT03914326 · 2019-06-17 · 2 site observations
COMPLETED
A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)NCT03172494 · 2017-05-26 · 1 site observation
COMPLETED
Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast CancerNCT03084237 · 2016-11-01 · 1 site observation
COMPLETED
Moderate Hypofractionated Radiotherapy for Lung CancerNCT03833193 · 2016-11-01 · 1 site observation
UNKNOWN
Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With HypertensionNCT02480764 · 2015-08-27 · 1 site observation
COMPLETED
Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast CancerNCT02482753 · 2015-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.